Article in Perfusion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Andrew ChevalierDivision of Pediatric Critical Care, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-8573-6185
Autumn McKniteDepartment of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0001-7985-2991
Aviva WhelanDivision of Pediatric Critical Care, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0001-8968-3183
Carina ImburgiaDepartment of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA.
Joseph E RowerDepartment of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA.
Kevin M WattDivision of Pediatric Critical Care, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
Danielle J GreenDivision of Pediatric Critical Care, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
Funding
The Indiana University-Ohio State University Maternal and Pediatric Precision in Therapeutics Data, Model, Knowledge, and Research Coordination Center (IU-OSU MPRINT DMKRCC)P30HD106451 · NICHD · INDIANA UNIVERSITY INDIANAPOLIS · PI Simon M. Lin · 2021 to 2026
$24.1M
Multidisciplinary Pulmonary and Critical Care Training ProgramT32HL105321 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Ramsey Hachem, Robert Paine · 2010 to 2026
$4.5M
Physiologically-Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life SupportR01HD097775 · NICHD · UNIVERSITY OF UTAH · PI WATT, KEVIN M · 2019 to 2023
$2.7M
Investigation of Drug-Drug and Drug-Circuit Interactions in Children on Continuous Renal Replacement TherapyF31DK130542 · NIDDK · UNIVERSITY OF UTAH · PI MCKNITE, AUTUMN · 2022 to 2023
BackgroundAzithromycin and methylprednisolone are two medications that are commonly used in patients who require ECMO support. Unfortunately, ECMO support can decrease drug concentrations through adsorption to circuit components. Such interactions have not been well described for either azithromycin or methylprednisolone. This study determined the extraction of these medications by ECMO circuits in an
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Interaction of azithromycin and methylprednisolone with ex-vivo extracorporeal membrane oxygenation circuits (ECMO). · full record | OpenQuestion